← Leaderboards
D Gail McCarver
Medical College Of Wisconsin
$6,267,204
Attributed
$6,267,204
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $978.8K · FY2005–13$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$6,267,204 · 6
By mechanism
R01$5,997,040 · 4
M01$270,164 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Genetic Polymorphism”
- Stephen S. Rich · University Of Alabama At Birmingham$76,268,916
- Richard K. Wilson · Washington University$49,172,943
- William J. Blot · Vanderbilt University$46,135,844
- Brian E Henderson · University Of Southern California$45,895,070
- David Heimbrook · Leidos Biomedical Research, Inc.$45,173,190
- Daniel H Geschwind · University Of California Los Angeles$44,299,523
Research focus
Genetic PolymorphismPregnancyGenotypeEmbryo /Fetus ToxicologyGenetic SusceptibilityGene Environment InteractionGas Chromatography Mass SpectrometryCytochrome P450Clinical ResearchAlcohol DehydrogenaseEnvironmental ExposureAfrican AmericanHuman Pregnant SubjectDoseEchocardiographyCongenital Heart DisorderFetusGeneticEvaluationChildEnzymesBiomarkerExhibitsEnvironmental Contamination
Grant awards (13)
Factors Determining Bisphenol A Disposition in Human Infants$432,260
R01 · FY2013 · ES · contact PI
Regulation of Drug Metabolizing Enzyme Ontogeny$537,671
R01 · FY2012 · GM · contact PI
Factors Determining Bisphenol A Disposition in Human Infants$441,132
R01 · FY2012 · ES · contact PI
Factors Determining Bisphenol A Disposition in Human Infants$443,579
R01 · FY2011 · ES · contact PI
Factors Determining Bisphenol A Disposition in Human Infants$470,593
R01 · FY2010 · ES · contact PI
CYP2E1 AND ADH IN HUMAN TRI TERATOGENECITY$88,155
M01 · FY2006 · RR · contact PI
Role of CYP2E1 and ADH in Human TRI Teratogenicity$749,075
R01 · FY2005 · ES
CYP2E1 AND ADH IN HUMAN TRI TERATOGENECITY$182,009
M01 · FY2005 · RR
Role of CYP2E1 and ADH in Human TRI Teratogenicity$726,881
R01 · FY2004 · ES
Role of CYP2E1 and ADH in Human TRI Teratogenicity$705,708
R01 · FY2003 · ES
Role of CYP2E1 and ADH in Human TRI Teratogenicity$685,154
R01 · FY2002 · ES
Role of CYP2E1 and ADH in Human TRI Teratogenicity$629,229
R01 · FY2001 · ES
CYP2E1 POLYMORPHISM--MECHANISM AND IMPACT ON DISEASE$175,758
R01 · FY2000 · AA